EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Promising predictive molecular biomarkers for cervical cancer (Review)

Marcela Lizano, Adela Carrillo-García, Erick De La Cruz-Hernández, Leonardo Josué Castro-Muñoz, Adriana Contreras-Paredes

International Journal of Molecular Medicine · 04.04.2024 · 53 (6)

DOI: 10.3892/ijmm.2024.5374 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 04.04.2024. Verfasst von Marcela Lizano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología, Universidad Nacional Autónoma de México, Mexico City 14080, Mexico. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer (CC) constitutes a serious public health problem. Vaccination and screening programs have notably reduced the incidence of CC worldwide by >80%; however, the mortality rate in low‑income countries remains high. The staging of CC is a determining factor in therapeutic strategies: The clinical management of early stages of CC includes surgery and/or radiotherapy, whereas radiotherapy and/or concurrent chemotherapy are the recommended therapeutic strategies for locally advanced CC. The histopathological characteristics of tumors can effectively serve as prognostic markers of radiotherapy response; however, the efficacy rate of radiotherapy may significantly differ among cancer patients. Failure of radiotherapy is commonly associated with a higher risk of recurrence, persistence and metastasis; therefore, radioresistance remains the most important and unresolved clinical problem. This condition highlights the importance of precision medicine in searching for possible predictive biomarkers to timely identify patients at risk of treatment response failure and provide tailored therapeutic strategies according to genetic and epigenetic characteristics. The present review aimed to summarize the evidence that supports the role of several proteins, methylation markers and non‑coding RNAs as potential predictive biomarkers for CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsFemaleHumansBiomarkers

Stichwörter der Autor:innen

DNA methylationcervical cancernon‑coding RNAspredictive biomarkerstreatment

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología, Universidad Nacional Autónoma de México, Mexico City 14080, Mexico.
  • Laboratorio de Investigación en Enfermedades Metabólicas e Infecciosas, División Académica Multidisciplinaria de Comalcalco, Universidad Juárez Autónoma de Tabasco, Ranchería Sur Cuarta Sección, Comalcalco City, Tabasco…
  • The Wistar Institute, Philadelphia, PA 19104, USA.

Zitieren

APA

Lizano, M., Carrillo-García, A., De La Cruz-Hernández, E., Castro-Muñoz, L. J., & Contreras-Paredes, A. (2024). Promising predictive molecular biomarkers for cervical cancer (Review). International Journal of Molecular Medicine, 53(6). https://doi.org/10.3892/ijmm.2024.5374

Vancouver

Lizano M, Carrillo-García A, De La Cruz-Hernández E, Castro-Muñoz LJ, Contreras-Paredes A. Promising predictive molecular biomarkers for cervical cancer (Review). International Journal of Molecular Medicine. 2024;53(6). doi:10.3892/ijmm.2024.5374

BibTeX
@article{Lizano2024,
  author = {Lizano, Marcela and Carrillo-García, Adela and De La Cruz-Hernández, Erick and Castro-Muñoz, Leonardo Josué and Contreras-Paredes, Adriana},
  title = {Promising predictive molecular biomarkers for cervical cancer (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  volume = {53},
  number = {6},
  doi = {10.3892/ijmm.2024.5374}
}
Kostenlos starten →